Physician profile
Timmy Lee
NPI 1275753147
$24,593.92
in general payments reported to CMS, 2019-2025
6 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,146 · 2021: $7,288 · 2022: $6,600 · 2023: $9,261 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,880 · Travel and Lodging: $381 · Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,880.00 |
| Travel and Lodging | $380.64 |
| Food and Beverage | $300.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $22,533.14 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $1,145.74 | 2019 | |
| Boston Scientific Corporation | $615.00 | 2023 | |
| Amgen INC. | $148.77 | 2025 | Tavneos |
| Travere Therapeutics, INC. | $131.78 | 2025 | |
| Kyowa Kirin, INC. | $19.49 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timmy Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.